Cooper Sara, Schmidt Bey-Marrié, Jama Ngcwalisa A, Ryan Jill, Leon Natalie, Mavundza Edison J, Burnett Rosemary J, Tanywe Asahngwa Constantine, Wiysonge Charles S
Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Cochrane Database Syst Rev. 2025 Apr 15;4(4):CD013430. doi: 10.1002/14651858.CD013430.pub2.
BACKGROUND: Human papillomavirus (HPV) vaccination in adolescents provides a powerful tool for preventing cervical cancer in women and other HPV-associated diseases in people of all genders. HPV vaccines have been progressively introduced in many countries. However, worldwide, many adolescents do not receive HPV vaccination, for various reasons. The HPV vaccine might be costly or unavailable, healthcare systems might lack capacity for its delivery, or adolescent health might not be prioritised. Some caregivers and adolescents may not accept available HPV vaccines and vaccination services. We currently lack a comprehensive understanding of the factors that influence HPV vaccination views and practices, and why some caregivers and adolescents may be less accepting of the vaccine. Qualitative research can contribute to this understanding and help inform policy and practice, including the development of more relevant, acceptable and effective interventions to promote public acceptance and uptake of HPV vaccination in adolescents. This qualitative evidence synthesis supplements a Cochrane review of the effectiveness of interventions to improve uptake of adolescent vaccination, including HPV vaccination. OBJECTIVES: The objectives of the review are to identify, appraise, and synthesise qualitative studies that explore caregivers' or adolescents' views, experiences, practices, intentions, decision-making, acceptance, hesitancy, or nonacceptance of HPV vaccination; to gain an understanding of the factors that influence caregiver and adolescent views and practices regarding HPV vaccination for adolescents; and to explore how the findings of this review can enhance our understanding of the related Cochrane intervention review. SEARCH METHODS: We searched MEDLINE, Embase, CINAHL, PsycInfo, and Scopus for eligible studies (February 2023). We updated this search in October 2024, but these results have not yet been fully incorporated. SELECTION CRITERIA: We included studies that utilised qualitative methods for data collection and analysis; focused on caregivers' or adolescents' views, practices, acceptance, hesitancy, or refusal of HPV vaccination for adolescents aged 9 to 19 years of age; and were from any setting globally where HPV vaccination is provided. DATA COLLECTION AND ANALYSIS: We used a prespecified sampling frame to capture a sample of eligible studies that were from a range of geographical and income-level settings, were conceptually rich in relation to the review's phenomenon of interest, and included HPV vaccination for diverse genders. We extracted contextual and methodological data from each sampled study. We used a thematic synthesis approach to analyse the evidence. We assessed methodological limitations using a list of criteria used in previous Cochrane reviews and originally based on the Critical Appraisal Skills Programme quality assessment tool for qualitative studies. We used the GRADE-CERQual (Confidence in the Evidence from Reviews of Qualitative research) approach to assess our confidence in each review finding. We integrated the findings of this review with those from the related Cochrane review of intervention effectiveness (by Abdullahi and colleagues), by mapping whether the trial interventions reflected or targeted the factors identified by this review as influencing caregivers' or adolescents' views and practices regarding HPV vaccination. MAIN RESULTS: We included 206 studies in the review and sampled 71 of these for our synthesis. Of these, 35 studies were conducted in high-income countries, 26 studies in middle-income countries, 8 studies in low-income countries, and 2 studies in multiple-income settings. Studies came from all six World Health Organization (WHO) regions and included urban and rural settings. We downgraded our confidence in several findings, mainly due to concerns about how the studies were conducted (methodological limitations), concerns about perspectives lacking from some types of participants or in some settings (relevance), or because of variability in the data or insufficient evidence to support all aspects of a review finding (coherence). Many complex factors were found to influence caregivers' and adolescents' HPV vaccination views and practices, which we categorised into eight overarching themes: 1) A lack of biomedical knowledge; 2) Perceptions of a range of interrelated risks and benefits (or lack thereof) associated with HPV vaccination; 3) Routine responses to vaccination generally or more specific views or experiences of other vaccines and vaccination programmes; 4) Complex nuclear familial decision-making dynamics; 5) Extended familial and social relations and networks, particularly extended family members, peers, traditional or religious leaders, and the media; 6) Interrelated socio-cultural beliefs and practices regarding adolescence, sexuality, gender, parenting and health; 7) Trust or distrust in the institutions, systems or experts associated with vaccination, most particularly teachers and the school, the pharmaceutical industry, government, science and biomedicine, and healthcare professionals; and 8) Access to, and experiences of, HPV vaccination programmes and delivery services, such as the convenience (or lack thereof) of HPV vaccination services, the cost of the vaccine, language barriers, the feminisation of HPV vaccination programmes and procedural aspects of school-based vaccination delivery. We did not identify any major differences in the occurrence of these overarching themes between subgroups. However, for various subthemes certain differences emerged in relation to place, gender and socio-economic status, and between caregivers and adolescents. The interventions tested in the related Cochrane review of intervention effectiveness most commonly targeted caregivers' and adolescents' lack of biomedical knowledge and their perceptions of the risks and benefits of HPV vaccination, with the other influencing factors identified by our review being underrepresented. AUTHORS' CONCLUSIONS: Our review reveals that caregivers' and adolescents' HPV vaccination views and practices are not only influenced by issues related to individual knowledge and perceptions of the vaccine, but also an array of more complex, contextual factors and meanings: social, political, economic, structural, and moral. Successful development of interventions to promote the acceptance and uptake of HPV vaccination for adolescents requires an understanding of the context-specific factors that influence HPV vaccination views and practices in the target setting. Through this, more tailored and in turn more relevant, acceptable, and effective responses could be developed. The eight overarching themes that emerged from our review could serve as a basis for gaining this understanding.
背景:青少年接种人乳头瘤病毒(HPV)疫苗是预防女性宫颈癌以及所有性别个体其他HPV相关疾病的有力工具。许多国家已逐步引入HPV疫苗。然而,在全球范围内,由于各种原因,许多青少年未接种HPV疫苗。HPV疫苗可能成本高昂或无法获取,医疗保健系统可能缺乏提供该疫苗的能力,或者青少年健康可能未被列为优先事项。一些照料者和青少年可能不接受现有的HPV疫苗及接种服务。我们目前对影响HPV疫苗接种观点和行为的因素,以及为何一些照料者和青少年可能不太接受该疫苗缺乏全面了解。定性研究有助于增进这方面的认识,并为政策和实践提供参考,包括制定更相关、可接受和有效的干预措施,以促进公众接受并推动青少年接种HPV疫苗。这一定性证据综述补充了Cochrane关于改善青少年疫苗接种(包括HPV疫苗接种)干预措施有效性的综述。 目的:本综述的目的是识别、评估和综合定性研究,这些研究探讨照料者或青少年对HPV疫苗接种的观点、经历、行为、意图、决策、接受程度、犹豫态度或拒绝情况;了解影响照料者和青少年对青少年HPV疫苗接种观点和行为的因素;并探讨本综述的结果如何增进我们对相关Cochrane干预综述的理解。 检索方法:我们检索了MEDLINE、Embase、CINAHL、PsycInfo和Scopus以查找符合条件的研究(2023年2月)。我们于2024年10月更新了此检索,但这些结果尚未完全纳入。 入选标准:我们纳入了采用定性方法进行数据收集和分析的研究;关注照料者或青少年对9至19岁青少年HPV疫苗接种的观点、行为、接受程度、犹豫态度或拒绝情况;且来自全球任何提供HPV疫苗接种的环境。 数据收集与分析:我们使用预先设定抽样框架,从一系列地理和收入水平环境中抽取符合条件的研究样本,这些研究在概念上与综述所关注的现象相关,且包括不同性别的HPV疫苗接种情况。我们从每个抽样研究中提取背景和方法学数据。我们采用主题综合法分析证据。我们使用先前Cochrane综述中使用的标准列表评估方法学局限性,该列表最初基于定性研究的批判性评估技能计划质量评估工具。我们使用GRADE-CERQual(定性研究综述证据的可信度)方法评估我们对每个综述结果的信心。我们通过绘制试验干预措施是否反映或针对本综述确定的影响照料者或青少年对HPV疫苗接种观点和行为的因素,将本综述的结果与相关Cochrane干预有效性综述(由Abdullahi及其同事进行)的结果进行整合。 主要结果:我们在综述中纳入了206项研究,并抽取了其中71项进行综合分析。其中,35项研究在高收入国家开展,26项在中等收入国家开展,8项在低收入国家开展,2项在多种收入环境中开展。研究来自世界卫生组织(WHO)的所有六个区域,包括城市和农村环境。我们对若干结果的信心有所降低,主要是因为对研究开展方式的担忧(方法学局限性)、对某些类型参与者或某些环境中缺乏观点的担忧(相关性),或者由于数据的变异性或证据不足以支持综述结果的所有方面(连贯性)。发现许多复杂因素影响照料者和青少年对HPV疫苗接种的观点和行为,我们将其归纳为八个总体主题:1)生物医学知识匮乏;2)对与HPV疫苗接种相关的一系列相互关联的风险和益处(或缺乏这些)的认知;3)对疫苗接种的常规反应或对其他疫苗及接种计划更具体的观点或经历;4)复杂的核心家庭决策动态;5)扩展的家庭和社会关系及网络,特别是大家庭成员、同龄人、传统或宗教领袖以及媒体;6)关于青春期、性、性别、育儿和健康的相互关联的社会文化信仰和实践;7)对与疫苗接种相关的机构、系统或专家的信任或不信任,最特别是教师和学校、制药行业、政府、科学和生物医学以及医疗保健专业人员;8)HPV疫苗接种计划和服务的获取情况及体验,例如HPV疫苗接种服务的便利性(或缺乏便利性)、疫苗成本、语言障碍、HPV疫苗接种计划的女性化以及学校接种服务的程序方面。我们未发现这些总体主题在各亚组中的出现情况有任何重大差异。然而,对于各种子主题,在地点、性别和社会经济地位方面以及照料者和青少年之间出现了某些差异。在相关的Cochrane干预有效性综述中测试的干预措施最常针对照料者和青少年生物医学知识的缺乏以及他们对HPV疫苗接种风险和益处的认知,而我们综述确定的其他影响因素则未得到充分体现。 作者结论:我们的综述表明,照料者和青少年对HPV疫苗接种的观点和行为不仅受到与个人对疫苗的知识和认知相关问题的影响,还受到一系列更复杂的背景因素和意义的影响:社会、政治、经济、结构和道德因素。要成功制定促进青少年接受并接种HPV疫苗的干预措施,需要了解影响目标环境中HPV疫苗接种观点和行为的具体背景因素。通过这样做,可以制定更具针对性,进而更相关、可接受和有效的应对措施。我们综述中出现的八个总体主题可作为获得这种理解的基础。
Cochrane Database Syst Rev. 2021-10-27
Cochrane Database Syst Rev. 2022-10-4
Cochrane Database Syst Rev. 2024-6-4
Cochrane Database Syst Rev. 2024-12-12
Cochrane Database Syst Rev. 2025-6-20
Vaccines (Basel). 2025-7-30
Cochrane Evid Synth Methods. 2025-1-13
Health Educ J. 2017-2
Asia Pac J Public Health. 2024-9
Vaccines (Basel). 2024-7-6
BMC Cancer. 2024-5-15